1. Home
  2. OSPN vs DNA Comparison

OSPN vs DNA Comparison

Compare OSPN & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$10.36

Market Cap

449.1M

Sector

Technology

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$6.85

Market Cap

418.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
DNA
Founded
1991
2008
Country
United States
United States
Employees
N/A
485
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
418.0M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
OSPN
DNA
Price
$10.36
$6.85
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$16.67
$8.50
AVG Volume (30 Days)
574.6K
1.1M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
5.02%
N/A
EPS Growth
28.77
N/A
EPS
1.88
N/A
Revenue
$243,180,000.00
N/A
Revenue This Year
$3.12
$1.60
Revenue Next Year
$3.42
N/A
P/E Ratio
$5.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.16
$5.00
52 Week High
$18.13
$17.58

Technical Indicators

Market Signals
Indicator
OSPN
DNA
Relative Strength Index (RSI) 38.66 43.18
Support Level $10.26 $6.46
Resistance Level $11.68 $10.05
Average True Range (ATR) 0.38 0.47
MACD -0.01 0.03
Stochastic Oscillator 19.59 69.06

Price Performance

Historical Comparison
OSPN
DNA

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: